IDEXX Laboratories, Inc. (IDXX) Q1 2023 Earnings Results

IDEXX Labs Beats on EPS, Stock Down 4.54%

IDEXX Labs reported better-than-expected earnings per share, which indicates strong performance in their operations. However, the stock fell by 4.54% following the earnings release, likely due to the lack of revenue details and forward guidance. Investors may be concerned about the absence of specific future targets amid ongoing supply chain issues.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$2.55	N/A	+6.74%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in their core business despite external challenges. They are optimistic about future growth opportunities.

Management highlighted strong demand in key segments.

They noted ongoing challenges in supply chain but remain focused on growth.

There was an emphasis on innovation and new product launches.

IDEXX Labs Beats on EPS, Stock Down 4.54%

Key numbers

Management commentary

IDEXX Laboratories, Inc.

More earnings this week

IDEXX Labs Beats on EPS, Stock Down 4.54%

Key numbers

Management commentary